Breathing machine helps the patient to breathe while they are suffering from chronic respiratory diseases or unable to breathe by themselves after anesthesia. Breathing machines are used during surgeries that require general anesthesia, as the medicines used to induce anesthesia can disrupt normal breathing. The machine is required after the surgery, as the patient may not be able to breathe immediately after the procedure. The type of breathing machine used varies according to the problem.
Ventilators are mainly used in emergency medicine, home care, intensive care medicine, and in anesthesia, as a component of an anesthesia machine. The oxygen concentrator delivers pure oxygen via a mask or nasal cannula. It may be used in hyperbaric chambers and oxygen therapy. A C-PAP (continuous positive airway pressure) breathing machine blows air into the nose through a mask, which in turn keeps the airway open and helps in the absorption of oxygen.
Nebulizers are generally used for the treatment of a range of respiratory disorders such as chronic obstructive pulmonary disease (COPD) and asthma. Medications are inhaled straight into the lungs for effective treatment. These machines aid people who suffer from asthma by delivering liquid medication through a mist, which is inhaled into the lungs via machine. These devices are majorly used in home care settings.
Breathing Machines Market Dynamics
Increasing number of respiratory disorders such as asthma and COPD, and rising number of surgeries are expected to drive growth of the global breathing machines market. According to the National Institute of Health data of 2014, asthma affects over 24 million people in the U.S., including over 6 million children. Breathing problems can also occur due to serious conditions such as pneumonia, tuberculosis, lung cancer, and other lung diseases. According to the World Health Organization (WHO) estimates, by 2030, the four major potentially fatal respiratory diseases including COPD, pneumonia, lung cancer, and tuberculosis will account for around one in five deaths worldwide.
Millions of people in the U.S. suffer from breathing problems such as chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema. COPD is a progressive life-threatening lung disease that causes breathlessness and predisposes to exacerbations and serious illness. In 2016, the Global Burden of Disease reported a prevalence of around 251 million cases of COPD worldwide. According to the same source, a total of 3.17 million deaths occurred due to COPD in 2015, which account for 5% of all deaths globally. COPD prevalence is expected to increase in the near future due to higher smoking prevalence and aging populations in many economies worldwide.
However, few drawbacks of breathing machines include throat discomfort, damage to vocal cords, and sleeping discomfort. Some complications of using a breathing machine may include lung damage, collapsed lung, pneumonia or infection. Moreover, constant medical care is required when a breathing machine is used. These factors are expected to hinder growth of the market.
Breathing Machines Market Regional Insights
On the basis of region, the global breathing machines market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold dominant position in the global breathing machines market in terms of revenue share, owing to increasing number of patients receiving treatments for respiratory diseases. According to COPD International, in 2016, around 12 million people in the U.S. were suffering from COPD and an estimated 12 million more were undiagnosed. According to a Centers for Disease Control and Prevention (CDC) report, it is the fourth leading cause of death in the U.S.
Asia Pacific breathing machines market is expected to exhibit highest CAGR, owing to continuously increasing number of surgeries and respiratory disease burden in the region. For instance, according to WHO 2017 report, over 90% of COPD deaths occur in low and middle-income economies. The primary cause of COPD is exposure to tobacco smoke. Other risk factors include exposure to indoor and outdoor air pollution and occupational fumes and dusts.
Breathing Machines Market: Competitive Landscape
Key players operating in the global breathing machines market include BD, Drager Medical, Fisher & Paykel, GE Healthcare, Invacare, Maque, Medtronic, OMRON, Philips Healthcare, Teijin Pharma Resmed, and Weinmann. Key players are focusing on improving breathing machines by developing energy-efficient power systems and product features such as lightweight maneuverability, long-lasting components, and patient-friendly design.
Breathing Machines Market: Taxonomy
On the basis of product type, the global breathing machines market is segmented into:
On the basis of end users, the global breathing machines market is segmented into:
On the basis of region, the global breathing machines market is segmented into:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.[email protected]
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.